{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T07:58:21Z","timestamp":1785484701958,"version":"3.56.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":43,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.lrr.2026.100569","type":"journal-article","created":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T23:41:03Z","timestamp":1771198863000},"page":"100569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Therapeutic outcomes of acute promyelocytic leukemia in children"],"prefix":"10.1016","volume":"25","author":[{"given":"Sirine","family":"Chatti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emna","family":"Azza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Bahri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roua","family":"Hsasna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosr Ben","family":"Abdennebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamia","family":"Aissaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.lrr.2026.100569_bib0001","doi-asserted-by":"crossref","first-page":"992","DOI":"10.18632\/oncotarget.27513","article-title":"Acute promyelocytic leukemia (APL): a review of the literature","volume":"11","author":"Jimenez","year":"2020","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.lrr.2026.100569_bib0002","first-page":"11","article-title":"Advances in pediatric acute promyelocytic leukemia","volume":"7","author":"Conneely","year":"2020","journal-title":"Child (Basel)"},{"issue":"4","key":"10.1016\/j.lrr.2026.100569_bib0003","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-103-4-620","article-title":"Proposed revised criteria for the classification of acute myeloid leukemia","volume":"103","author":"Bennett","year":"1985","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.lrr.2026.100569_bib0004","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1046\/j.1365-2141.1998.00871.x","article-title":"Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases","volume":"102","author":"Guglielmi","year":"1998","journal-title":"Br. J. Haematol"},{"issue":"4","key":"10.1016\/j.lrr.2026.100569_bib0005","first-page":"1247","article-title":"Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups","volume":"96","author":"Sanz","year":"2000","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.lrr.2026.100569_bib0006","doi-asserted-by":"crossref","first-page":"e6697","DOI":"10.1002\/ccr3.6697","article-title":"Differentiation syndrome in patients with acute promyelocytic leukemia","volume":"11","author":"Elamin","year":"2023","journal-title":"Clin. Case Rep."},{"issue":"1","key":"10.1016\/j.lrr.2026.100569_bib0007","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2012.012","article-title":"Diagnosis and treatment of acute promyelocytic leukemia in children: the experience in China","volume":"4","author":"Zhang","year":"2012","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"issue":"2","key":"10.1016\/j.lrr.2026.100569_bib0008","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.blre.2014.09.013","article-title":"Global characteristics of childhood acute promyelocytic leukemia","volume":"29","author":"Zhang","year":"2015","journal-title":"Blood Rev."},{"key":"10.1016\/j.lrr.2026.100569_bib0009","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1200\/JCO.1990.8.11.1913","article-title":"The unique aspects of acute promyelocytic leukemia","volume":"8","author":"Stone","year":"1990","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.lrr.2026.100569_bib0010","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-18278-x","article-title":"Influence of body mass index on incidence and prognosis of acute myeloid leukemia and acute promyelocytic leukemia: a meta-analysis","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.lrr.2026.100569_bib0011","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29613","article-title":"Obesity in children with acute promyelocytic leukemia: what is its prevalence and prognostic significance?","volume":"69","author":"Laurie","year":"2022","journal-title":"Pediatr. Blood Cancer"},{"issue":"1","key":"10.1016\/j.lrr.2026.100569_bib0012","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2014.032","article-title":"Acute promyelocytic leukemia (APL): comparison between children and adults","volume":"6","author":"Testi","year":"2014","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"issue":"12","key":"10.1016\/j.lrr.2026.100569_bib0013","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/MPH.0b013e31815a05aa","article-title":"The development of a novel protocol for the treatment of de novo childhood acute myeloid leukemia in a single institution in Taiwan","volume":"29","author":"Yeh","year":"2007","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"25","key":"10.1016\/j.lrr.2026.100569_bib0014","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1182\/blood-2010-06-288613","article-title":"Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group","volume":"116","author":"Tallman","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.lrr.2026.100569_bib0015","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3324\/haematol.2009.013243","article-title":"Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy","volume":"95","author":"Cervera","year":"2010","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.lrr.2026.100569_bib0016","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1182\/blood-2003-07-2462","article-title":"Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group","volume":"103","author":"Sanz","year":"2004","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.lrr.2026.100569_bib0017","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1080\/10428194.2019.1581187","article-title":"Predictors of early hemorrhage in acute promyelocytic leukemia","volume":"60","author":"Naymagon","year":"2019","journal-title":"Leuk. Lymphoma"},{"issue":"4","key":"10.1016\/j.lrr.2026.100569_bib0018","first-page":"509","article-title":"Impact of international collaboration on the prognosis of childhood acute promyelocytic leukemia in Iraq","volume":"91","author":"Testi","year":"2006","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.lrr.2026.100569_bib0019","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1182\/blood-2004-05-1971","article-title":"GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children","volume":"106","author":"Testi","year":"2005","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.lrr.2026.100569_bib0020","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.clml.2015.11.018","article-title":"Pseudotumor cerebri in acute promyelocytic leukemia patients on Intergroup Protocol 0129: clinical description and recommendations for new diagnostic criteria","volume":"16","author":"Coombs","year":"2016","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"30","key":"10.1016\/j.lrr.2026.100569_bib0021","doi-asserted-by":"crossref","first-page":"7632","DOI":"10.1200\/JCO.2005.01.3359","article-title":"Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA Group","volume":"23","author":"Ortega","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.lrr.2026.100569_bib0022","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/jamaoncol.2021.5206","article-title":"Assessment of arsenic trioxide and all-trans retinoic acid for the treatment of pediatric acute promyelocytic leukemia: a report from the children\u2019s Oncology Group AAML1331 trial","volume":"8","author":"Kutny","year":"2022","journal-title":"JAMA Oncol."},{"issue":"6","key":"10.1016\/j.lrr.2026.100569_bib0023","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/ajh.23158","article-title":"Bleeding and thrombosis in acute promyelocytic leukemia","volume":"87","author":"Choudhry","year":"2012","journal-title":"Am. J. Hematol."}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048926000099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048926000099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T07:11:18Z","timestamp":1785481878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048926000099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":23,"alternative-id":["S2213048926000099"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2026.100569","relation":{},"ISSN":["2213-0489"],"issn-type":[{"value":"2213-0489","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic outcomes of acute promyelocytic leukemia in children","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2026.100569","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100569"}}